RxDoctor Payments Data

Laura Peralta, DO

Family Medicine · Weston, FLNPI 1568512598

Payments from drug & device makers

$916in general payments, 2019–2025

Across 35 payments — averaging $26.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$254
  • Lilly USA, LLC$210
  • Novo Nordisk$142
  • Pfizer$85
  • Terumo Medical Corporation$63
  • Amarin Pharma, Inc.$30
  • plus $133 from 6 others

What the payments were for

  • Food & beverage$90899%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$916 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$31,609
Medicare patients
65
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide38$42,831
EliquisApixaban38$41,021
OzempicSemaglutide24$31,329
FarxigaDapagliflozin Propanediol22$22,129
JardianceEmpagliflozin19$20,021
AbrysvoRsv Vacc, Pref A And Pref B/Pf11$3,334
Atorvastatin Calcium194$2,392
Rosuvastatin Calcium126$1,687
Omeprazole75$1,633
Levothyroxine Sodium103$1,014
Metoprolol Succinate58$948
Lisinopril100$744
Fluticasone Propionate44$714
Amlodipine Besylate107$701
Metformin Hcl ErMetformin Hcl70$688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$85$44,35449 claims
Lilly USA, LLCTrulicity$210$42,83138 claims
Novo NordiskOzempic$142$31,32924 claims
Boehringer IngelheimJardiance$21$20,02119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Weston

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →